PT  - JOURNAL ARTICLE
AU  - Mori, Y
AU  - Sakai, Y
AU  - Kuroda, N
AU  - Yokoya, F
AU  - Toyoshi, K
AU  - Horie, M
AU  - Baba, S
TI  - Further structural analysis of urinary metabolites of suprofen in the rat.
DP  - 1984 Nov 01
TA  - Drug Metabolism and Disposition
PG  - 767--771
VI  - 12
IP  - 6
4099  - http://dmd.aspetjournals.org/content/12/6/767.short
4100  - http://dmd.aspetjournals.org/content/12/6/767.full
SO  - Drug Metab Dispos1984 Nov 01; 12
AB  - The urinary metabolites of 2-(4-(2-thienylcarbonyl)phenyl)propionic acid (suprofen, S) in rats were analyzed by radio-GC, GC/MS, or 1H NMR technique. Radio-GC analysis of trimethylsilylated materials after TLC separation of intact urine showed the presence of three radioactive peaks with the retention times corresponding to the authentic S, 2-(4-(2-thienylhydroxymethyl)phenyl)propionic acid, and 2-(4-carboxyphenyl)propionic acid. About 40% of the total radioactivity appearing in the 0-24-hr urine was accounted for by the three metabolites and their conjugates. The identification of these metabolites was confirmed by comparison of the MS spectra of urine, in which rats were administered an equimolar mixture of S and S[phenyl-d4], with those of synthetic standards. The labile metabolites of S, corresponding to about 32% of the total radioactivity appearing in the 0-24-hr urine, were isolated and purified by ether extraction from the fresh urine and GC/MS or HPLC. GC/MS of the methylated metabolite revealed the consistent presence of the ion peaks at m/z 304, 245, 217, and 141, indicative of a dimethylated product with monohydroxy group on the thiophene ring. Analysis of the 1H NMR spectrum demonstrated the metabolite to be 2-(4-(5-hydroxy-2-thienylcarbonyl)phenyl)propionic acid.